These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 69003)

  • 61. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
    Pettey CL; Collins JJ
    Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
    DeLeo AB; Shiku H; Takahashi T; John M; Old LJ
    J Exp Med; 1977 Sep; 146(3):720-34. PubMed ID: 197192
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. III. Alterations of splenic B and T cells in Friend virus-infected mice.
    Cerny J; Essex M; Thomas DB
    Int J Cancer; 1976 Aug; 18(2):197-204. PubMed ID: 60287
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 67. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ
    J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of the Friend leukemia virus on lymphocyte subpopulations in the mouse].
    Jezzi T; Premrov MG; Del Gobbo V; Garaci E
    Ann Ist Super Sanita; 1982; 18(3):513-5. PubMed ID: 6230037
    [No Abstract]   [Full Text] [Related]  

  • 69. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR
    Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 71. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Study of group- and type-specific antigens in the process of development of viral murine leukemias].
    Gurtsevich VE; Mazurenko NP
    Vopr Onkol; 1973; 19(1):66-70. PubMed ID: 4121908
    [No Abstract]   [Full Text] [Related]  

  • 74. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 75. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
    Klarnet JP; Kern DE; Okuno K; Holt C; Lilly F; Greenberg PD
    J Exp Med; 1989 Feb; 169(2):457-67. PubMed ID: 2562982
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Arming of macrophages with lymphocytes from mice immunized with tumor tissue.
    Horowitz M; Argyris BF
    Immunol Commun; 1977; 6(3):297-319. PubMed ID: 69610
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Selective failure of accessory cell function in Moloney murine leukemia virus-tolerant mice.
    Biasi G; Collavo D; Chieco-Bianchi L
    J Immunol; 1983 Jul; 131(1):16-8. PubMed ID: 6223070
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nature of the stimulating cell in the syngeneic and the allogeneic mixed lymphocyte reaction in mice.
    Von Boehmer H; Shortman K; Adams P
    J Exp Med; 1972 Dec; 136(6):1648-60. PubMed ID: 4539312
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Studies of the mechanisms for the induction of in vivo tumor immunity. I. Induction of primary and secondary cell-mediated cytotoxic responses by adoptive transfer of lymphocytes.
    Ting CC
    Cell Immunol; 1976 Nov; 27(1):71-81. PubMed ID: 136303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.